Artikel Referenzen

Auf dieser Seiten finden Sie alle Referenzen der jeweiligen Artikel. Beachten Sie dazu einfach die Überschrift um die Referenzen zuzuordnen. Für weitere Fragen stehen wir Ihnen gerne zur Verfügung. Verwenden Sie dazu unser Kontaktformular.

1. Referenzen für folgende Artikel:

Alles über Grüner Tee | Grüner Tee zum abnehmen | Die 10 wichtigsten Vorteile von Grüner Tee | Ist grüner Tee gesund | Gesund leben mit Grüner Tee | Warum ist Grüner Tee ein Superfood? | Grüner Tee und seine besonderen Eigenschaften | Grüner Tee – Fragen und Antworten zum abnehmen | Ist grüner Tee zum abnehmen geeignet? | Grüner Tee – welche Wirkung erwartet mich? | Kann Grüner Tee Krebs vorbeugen? | Trinkt deine Mutter grüner Tee? | Wie gesund ist Grüner Tee? | Grüner Tee Inhaltsstoffe | Hält Grüner Tee fit? | Aufguss Grüner Tee | 7 Gründe warum Grüner Tee gesund ist | Schützt Grüner Tee das Herz? | Wie wirkt Grüner Tee? | 11 Grüner Tee Vorteile | 6 Besondere Grüner Tee Sorten | Grüner Tee Wirkung – 20 Fakten | Wirkung von Grüner Tee | Richtig abnehmen mit Grüner Tee | 7 Diät Tipps mit grüner Tee | Hilft Grüner Tee beim Abnehmen |

Chow HH, Hakim IA, Vining DR, et al. Modulation of human glutathione s-transferases by polyphenon e intervention. Cancer Epidemiol Biomarkers Prev. 2007 Aug;16(8):1662-6. 2007. PMID:17684143.

Coimbra S, Castro E, Rocha-Pereira P, Rebelo I, Rocha S, Santos-Silva A. The effect of green tea in oxidative stress. Clin Nutr. 2006 Oct;25(5):790-6. Epub 2006 May 15. 2006. PMID:16698148.

Kuriyama S, Shimazu T, Ohmori K, Kikuchi N, Nakaya N, Nishino Y, Tsubono Y, Tsuji I. Green tea consumption and mortality in Japan. JAMA. 2006 Sep 13;296(10):1255-65. PubMed

Kuriyama S, Hozawa A, Ohmori K, Shimazu T, Matsui T, Ebihara S, Awata S, Nagatomi R, Arai H, Tsuji I. Green tea consumption and cognitive function: the Tsurugaya Project 1. Am J Clin Nutr. 2006 Feb;83(2):355-61.

Kaur T, Pathak CM, Pandhi P, Khanduja KL. Green tea extract and learning, memory, behavior and acetylcholinesterase activity in young and old male rats. Brain Cogn. 2007 Dec 8 PubMed

Dulloo AG, Duret C, Rohrer D, Girardier L, Mensi N, Fathi M, Chantre P, Vandermander J. Green tea extract rich in catechin polyphenols and caffeine in increasing energy expenditure and fat oxidation in humans. Am J Clin Nutr. 1999 Dec;70(6):1040-5. PubMed

Auvichayapat P, Prapochanung M, Tunkamnerdthai O, Sripanidkulchai BO, Auvichayapat N, Thinkhamrop B, Kunhasura S, Wongpratoom S, Sinawat S, Hongprapas P. Green tea and weight reduction in obese Thais. Physiol Behav. 2007 Oct 18 PubMed

Gross G, Meyer KG, Pres H, Thielert C, Tawfik H, Mescheder A. A randomized, double-blind, four-arm parallel-group, placebo-controlled Phase II/III study to investigate the clinical efficacy of two galenic formulations of Polyphenon(R) E in the treatment of external genital warts. J Eur Acad DermatolVenereol. 2007;21(10):1404-12.

Heck AM, DeWitt BA, Lukes AL. Potential interactions between alternative therapies and warfarin. [review]. Am J Health Syst Pharm. 2000 Jul 1;57(13):1221-1227.

Chwan-Li Shen, James K. Yeh, Jay Cao, and Jia-Sheng Wang, Green Tea and Bone metabolism http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2754215/ | PMCID: PMC2754215 | NIHMSID: NIHMS129754 PMC 2010 Jul 1

Belza A, Toubro S, Astrup A. The effect of caffeine, green tea and tyrosine on thermogenesis and energy intake. Eur J Clin Nutr. 2007; [Epub ahead of print].

Park, Jae-Hyung et al. Green tea extract with polyethylene glycol-3350 reduces body weight and improves glucose tolerance in db/db and high-fat diet mice. Naunyn-Schmiedeberg’s Archives of Pharmacology, 2013 DOI: 10.1007/s00210-013-0869-9

Bettuzzi S, Brausi M, Rizzi F, Castagnetti G, Peracchia G, Corti A. Chemoprevention of human prostate cancer by oral administration of green tea catechins in volunteers with high-grade prostate intraepithelial neoplasia: a preliminary report from a one-year proof-of-principle study. Cancer Res. 2006;66(2):1234-40.

Borrelli F, Capasso R, Russo A, Ernst E. Systematic review: green tea and gastrointestinal cancer risk. Aliment Pharmacol Ther Mar 1, 2004;19(5):497-510.

Boschmann M, Thielecke F. The effects of epigallocatechin-3-gallate on thermogenesis and fat oxidation in obese men: a pilot study. J Am Coll Nutr. 2007;26(4):389S-395S.

J Am Acad Dermatol. 2001 Mar;44(3):425-32.
Cutaneous photoprotection from ultraviolet injury by green tea polyphenols. Elmets CA1, Singh D, Tubesing K, Matsui M, Katiyar S, Mukhtar H. PMID: 11209110

Brown AL, Lane J, Holyoak C, Nicol B, Mayes AE, Dadd T. Health effects of green tea catechins in overweight and obese men: a randomised controlled cross-over trial. Br J Nutr. 2011 Jun 7:1-10. [Epub ahead of print]

Cooper R, Morre DJ, Morre DM. Medicinal benefits of green tea: Part I. Review of noncancer health benefits. J Altern Complement Med. 2005;11(3):521-8.

Diepvens K, Westerterp KR, Westerterp-Plantenga MS. Obesity and thermogenesis related to the consumption of caffeine, ephedrine, capsaicin and green tea. Am J Physiol Regul Integr Comp Physiol. 2007;292(1):R77-85.

Journal of Food Science, 2010; Pediatrics, 2011; USDA National Nutrient Database for Standard Reference, Release 26; Journal of Analytical Toxicology, 2006; Starbucks, 2014; Food and Chemical Toxicology, 2014; Keurig, 2014

Journal of Food Science, 2010; Pediatrics, 2011; Journal of Analytical Toxicology, 2008; USDA National Nutrient Database for Standard Reference, Release 26; Journal of Analytical Toxicology, 2006; Starbucks, 2014; Food and Chemical Toxicology, 2014

Fritz H, Seely D, Kennedy DA, Fernandes R, Cooley K, Fergusson D. Green tea and lung cancer: a systemic review. Integr Cancer Ther. 20133; 12(1):7-24.

Fujita H, Yamagami T. Antihypercholesterolemic effect of Chinese black tea extract in human subjects with borderline hypercholesterolemia. Nutr Res. 2008;28(7):450-6.

Fukino Y, Ikeda A, Maruyama K, Aoki N, Okubo T, Iso H. Randomized controlled trial for an effect of green tea-extract powder supplementation on glucose abnormalities. Eur J Clin Nutr. 2007; [Epub ahead of print].

Hsu CH, Liao YL, Lin SC, Tsai TH, Huang CJ, Chou P. Does supplementation with green tea extract improve insulin resistance in obese type 2 diabetics? A randomized, double-blind, and placebo-controlled clinical trial. Altern Med Rev. 2011 Jun;16(2):157-63.

Degradation of Green Tea Catechins in Tea Drinks
Zhen-Yu Chen , Qin Yan Zhu , David Tsang , and Yu Huang
Departments of Biochemistry and Physiology, The Chinese University of Hong Kong, Shatin, New Territories, Hong Kong, The People’s Republic of China
J. Agric. Food Chem., 2001, 49 (1), pp 477–482
DOI: 10.1021/jf000877h Publication Date (Web): December 20, 2000

Inoue M, Tajima K, Mizutani M, et al. Regular consumption of green tea and the risk of breast cancer recurrence: follow-up study from the Hospital-based Epidemiologic Research Program at Aichi Cancer Center (HERPACC), Japan. Cancer Lett. 2001;167(2):175-182.

Jian L, Xie LP, Lee AH, Binns CW. Protective effect of green tea against prostate cancer: a case-control study in southeast China. Int J Cancer Jan 1, 2004;108(1):130-135.

Jin X, Zheng RH, Li YM. Green tea consumption and liver disease: a systematic review. Liver Int. 2008;28(7):990-6.

Katiyar SK, Ahmad N, Mukhtar H. Green tea and skin. Arch Dermatol. 2000;136(8):989-94.

Kato A, Minoshima Y, Yamamoto J, Adachi I, Watson AA, Nash RJ. Protective effects of dietary chamomile tea on diabetic complications. J Agric Food Chem. 2008;56(17):8206-11.

Kimura K, Ozeki M, Juneja LR, Ohira H. L-Theanine reduces psychological and physiological stress responses. Biol Psychol. 2007;74(1):39-45.

Pianetti S, Guo S, Kavanagh KT, Sonenshein GE. Green tea polyphenol epigallocatechin-3 gallate inhibits Her-2/neu signaling, proliferation, and transformed phenotype of breast cancer cells. Cancer Res. 2002;62(3):652-655.

Rakel. Integrative Medicine, 3rd ed. Philadelphia, PA: Saunders, An Imprint of Elsevier; 2012.

Koo SI, Noh SK. Green tea as inhibitor of the intestinal absorption of lipids: potential mechanism for its lipid-lowering effect. J Nutr Biochem. 2007;18(3):179-83.

Kovacs EM, Lejeune MP, Nijs I, Westerterp-Plantenga MS. Effects of green tea on weight maintenance after body-weight loss. Br J Nutr Mar 1, 2004;91(3):431-437.

Kuriyama S, Shimazu T, Ohmori K, Kikuchi N, Nakaya N, Nishino Y, Tsubono Y, Tsuji I. Green tea consumption and mortality due to cardiovascular disease, cancer and all causes in Japan: the Ohsaki study. JAMA. 2006;296(10):1255-65.

Lee W, Min WK, Chun S, Lee YW, Park H, Lee do H, Lee YK, Son JE. Long-term effects of green tea ingestion on atherosclerotic biological markers in smokers. Clin Biochem. Jan 1, 2005;38(1):84-87.

Low Dog T, Riley D, Carter T. Traditional and alternative therapies for breast cancer. Alt Ther. 2001;7(3):36-47.

Alessio HM. Exercise-induced oxidative stress. Med Sci Sports Exerc 25: 218–224, 1993.

Barclay JK and Hansel M. Free radicals may contribute to oxidative skeletal muscle fatigue. Can J Physiol Pharmacol 69: 279–284, 1991.

Schwarz A, Maeda A, Gan D, Mammone T, Matsui MS, Schwarz T. Green tea phenol extracts reduce UVB-induced DNA damage in human cells via interleukin-12. Photochem Photobiol. 2008 Jan 7

Chiu AE, Chan JL, Kern DG, Kohler S, Rehmus WE, Kimball AB. Green tea extracts in the clinical and histologic appearance of photoaging skin. Dermatol Surg. 2005 Jul;31(7 Pt 2):855-60; discussion 860. PubMed

Erba D, Riso P, Bordoni A, Foti P, Biagi PL, Testolin G. J Nutr Biochem. 2005 Mar;16(3):144-9. PubMed

Koo SI, Noh SK. J Nutr Biochem. 2007 Mar;18(3):179-83. PubMed

Iso H, Date C, Wakai K, Fukui M, Tamakoshi A; JACC Group. Ann Intern Med. 2006 Apr 18;144(8):554-62.

Fukino Y, Ikeda A, Maruyama K, Aoki N, Okubo T, Iso H. Green tea-extract powder supplementation and glucose abnormalities. Eur J Clin Nutr. 2007 Jun 6

Sano J, Inami S, Seimiya K, Ohba T, Sakai S, Takano T, Mizuno K. Circ J. 2004 Jul;68(7):665-70. PubMed

Chyu KY, Babbidge SM, Zhao X, Dandillaya R, Rietveld AG, Yano J, Dimayuga P, Cercek B, and Shah PK. Differential effects of green tea-derived catechin on developing versus established atherosclerosis in apolipoprotein E-null mice. Circulation 109: 2448–2453, 2004.

Coburn CT, Knapp FF Jr, Febbraio M, Beets AL, Silverstein RL, and Abumrad NA. Defective uptake and utilization of long-chain fatty acids in muscle and adipose tissues of CD36 knockout mice. J Biol Chem 275: 32523–32529, 2000.

Collomp K, Ahmaidi S, Audran M, Chanal JL, and Prefaut C. Effects of caffeine ingestion on performance and anaerobic metabolism during the Wingate Test. Int J Sports Med 12: 439–443, 1991.

Costet P, Legendre C, More J, Edgar A, Galtier P, and Pineau T. Peroxisome proliferator-activated receptor α-isoform deficiency leads to progressive dyslipidemia with sexually dimorphic obesity and steatosis. J Biol Chem 273: 29577–29585, 1998.

Costill DL, Dalsky GP, and Fink WJ. Effects of caffeine ingestion on metabolism and exercise performance. Med Sci Sports 10: 155–158, 1978.

Dulloo AG, Duret C, Rohrer D, Girardier L, Mensi N, Fathi M, Chantre P, and Vandermander J. Efficacy of a green tea extract rich in catechin polyphenols and caffeine in increasing 24-h energy expenditure and fat oxidation in humans. Am J Clin Nutr 70: 1040–1045, 1999.

Effect of green tea catechins with or without caffeine on anthropometric measures: a systematic review and meta-analysis
Olivia J Phung, William L Baker, Leslie J Matthews, Michael Lanosa, Alicia Thorne, and Craig I Coleman
From the University of Connecticut School of Pharmacy, Storrs, CT (OJP, WLB, LJM, ML, and CIC); the Department of Drug Information at Hartford Hospital, Hartford, CT (OJP and WLB); and the Cleveland Clinic, Cleveland, OH (AT).
We certify that none of the material in this manuscript was previously published, and the study was not funded.
Address correspondence to CI Coleman, University of Connecticut School of Pharmacy, Pharmacoeconomics and Outcomes Studies Group, Hartford Hospital, 80 Seymour Street, Hartford, CT 06102-5037

Graham TE and Spriet LL. Metabolic, catecholamine, and exercise performance responses to various doses of caffeine. J Appl Physiol 78: 867–874, 1995.

Guerre-Millo M, Gervois P, Raspe E, Madsen L, Poulain P, Derudas B, Herbert JM, Winegar DA, Willson TM, Fruchart JC, Berge RK, and Staels B. Peroxisome proliferator-activated receptor α activators improve insulin sensitivity and reduce adiposity. J Biol Chem 275: 16638–16642, 2000.

Hawley JA, Brouns F, and Jeukendrup A. Strategies to enhance fat utilisation during exercise. Sports Med 25: 241–257, 1998.

Horowitz JF and Klein S. Lipid metabolism during endurance exercise. Am J Clin Nutr 72: 558S–563S, 2000.

Howlett RA, Gonzalez NC, Wagner HE, Fu Z, Britton SL, Koch LG, and Wagner PD. Selected contribution: skeletal muscle capillarity and enzyme activity in rats selectively bred for running endurance. J Appl Physiol 94: 1682–1688, 2003.

Ibrahimi A and Abumrad NA. Role of CD36 in membrane transport of long-chain fatty acids. Curr Opin Clin Nutr Metab Care 5: 139–145, 2002.

Ishihara K, Oyaizu S, Onuki K, Lim K, and Fushiki T. Chronic(−)-hydroxycitrate administration spares carbohydrate utilization and promotes lipid oxidation during exercise in mice. J Nutr 130: 2990–2995, 2000.

Ivy JL, Costill DL, Fink WJ, and Lower RW. Influence of caffeine and carbohydrate feedings on endurance performance. Med Sci Sports 11: 6–11, 1979.

Jeukendrup AE, Saris WH, and Wagenmakers AJ. Fat metabolism during exercise: a review. Part II: regulation of metabolism and the effects of training. Int J Sports Med 19: 293–302, 1998.

Estimated Dietary Flavonoid Intake and Major Food Sources of U.S. Adults
Ock Kyoung Chun, Sang Jin Chung, and Won O. Song3,
Department of Food Science and Human Nutrition, Michigan State University, East Lansing, MI 48824 and 4Department of Foods and Nutrition, Kookmin University, Seoul, Korea 136-702

Jeukendrup AE, Saris WH, and Wagenmakers AJ. Fat metabolism during exercise: a review. Part III: effects of nutritional interventions. Int J Sports Med 19: 371–379, 1998.

Kim KM, Kawada T, Ishihara K, Inoue K, and Fushiki T. Increase in swimming endurance capacity of mice by capsaicin-induced adrenal catecholamine secretion. Biosci Biotechnol Biochem 61: 1718–1723, 1997.

Kim KM, Kawada T, Ishihara K, Inoue K, and Fushiki T. Swimming capacity of mice is increased by oral administration of a nonpungent capsaicin analog, stearoyl vanillylamide. J Nutr 128: 1978–1983, 1998.

Kopelman PG. Obesity as a medical problem. Nature 404: 635–643, 2000.

Lee HJ, Choi SS, Park MK, An YJ, Seo SY, Kim MC, Hong SH, Hwang TH, Kang DY, Garber AJ, and Kim DK. Fenofibrate lowers abdominal and skeletal adiposity and improves insulin sensitivity in OLETF rats. Biochem Biophys Res Commun 296: 293–299, 2002.

Leijten PA and van Breemen C. The effects of caffeine on the noradrenaline-sensitive calcium store in rabbit aorta. J Physiol 357: 327–339, 1984.

Lew EA and Garfinkel L. Variations in mortality by weight among 750,000 men and women. J Chronic Dis 32: 563–576, 1979.

Matsumoto K, Ishihara K, Tanaka K, Inoue K, and Fushiki T. An adjustable-current swimming pool for the evaluation of endurance capacity of mice. J Appl Physiol 81: 1843–1849, 1996.

Mikami Y, Toda M, Watanabe M, Nakamura M, Toyama Y, and Kawakami Y. A simple and reliable behavioral analysis of locomotor function after spinal cord injury in mice. J Neurosurg Spine 97: 142–147, 2002.

Miller YD and Dunstan DW. The effectiveness of physical activity interventions for the treatment of overweight and obesity and type 2 diabetes. J Sci Med Sport 7, Suppl 1: 52–59, 2004.

Miura Y, Chiba T, Tomita I, Koizumi H, Miura S, Umegaki K, Hara Y, Ikeda M, and Tomita T. Tea catechins prevent the development of atherosclerosis in apoprotein E-deficient mice. J Nutr 131: 27–32, 2001.

Mizunoya W, Oyaizu S, Ishihara K, and Fushiki T. Protocol for measuring the endurance capacity of mice in an adjustable-current swimming pool. Biosci Biotechnol Biochem 66: 1133–1136, 2000.

Murase T, Nagasawa A, Suzuki J, Hase T, and Tokimitsu I. Beneficial effects of tea catechins on diet-induced obesity: stimulation of lipid catabolism in the liver. Int J Obes Relat Metab Disord 26: 1459–1464, 2002.

Nagao T, Komine Y, Soga S, Meguro S, Hase T, Tanaka Y, and Tokimitsu I. Ingestion of a tea beverage rich in catechins leads to a reduction in body fat and malondialdehyde-LDL in men. Am J Clin Nutr. In press.

GREEN TEA – Get complete, unbiased, scientific information on GREEN TEA, including Safety Ratings,
http://naturaldatabase.therapeuticresearch.com/%28X%281%29S%28xcgmlu45fzpp5b45txtuwh55%29%29/nd/Search.aspx?cs=&s=nd&pt=100&id=960&AspxAutoDetectCookieSupport=1
Effectiveness Ratings, Interaction Ratings, Lists of Ingredients and Adverse
Reactions… all from Natural Medicines Comprehensive DatabaseTherapeutic Research Faculty, publishers of Natural Medicines
Comprehensive Database, Prescriber’s Letter, and Pharmacist’s Letter.

Novelli GP, Bracciotti G, and Falsini S. Spin-trappers and vitamin E prolong endurance to muscle fatigue in mice. Free Radic Biol Med 8: 9–13, 1990.

Reid MB, Haack KE, Franchek KM, Valberg PA, Kobzik L, and West MS. Reactive oxygen in skeletal muscle. I. Intracellular oxidant kinetics and fatigue in vitro. J Appl Physiol 73: 1797–1804, 1992.

Reid MB, Stokic DS, Koch SM, Khawli FA, and Leis AA. N-acetylcysteine inhibits muscle fatigue in humans. J Clin Invest 94: 2468–24674, 1994.

Rice-Evans CA, Miller NJ, and Paganga G. Structure-antioxidant activity relationships of flavonoids and phenolic acids. Free Radic Biol Med 20: 933–956, 1996.

Ryan DH. Diet and exercise in the prevention of diabetes. Int J Clin Pract Suppl 134: 28–35, 2003.

Schoonjans K, Staels B, and Auwerx J. Role of the peroxisome proliferator-activated receptor (PPAR) in mediating the effects of fibrates and fatty acids on gene expression. J Lipid Res 37: 907–925, 1996.

Townsend PA, Scarabelli TM, Pasini E, Gitti G, Menegazzi M, Suzuki H, Knight RA, Latchman DS, Stephanou A. Epigallocatechin-3-gallate inhibits STAT-1 activation and protects cardiac myocytes from ischemia/reperfusion-induced apoptosis. FASEB J. 2004 Oct;18(13):1621-3.

Kim JA, Formoso G, Li Y, Potenza MA, Marasciulo FL, Montagnani M, Quon MJ. Epigallocatechin gallate mediates NO-dependent vasodilation using signaling pathways in vascular endothelium. J Biol Chem. 2007 May 4;282(18):13736-45. PubMed

Yang YC, Lu FH, Wu JS, Wu CH, Chang CJ. Arch Intern Med. 2004 Jul 26;164(14):1534-40. PubMed

Sato Y, Nakatsuka H, Watanabe T, Hisamichi S, Shimizu H, Fujisaku S, Ichinowatari Y, Ida Y, Suda S, Kato K, et al. Possible contribution of green tea drinking habits to the prevention of stroke. Tohoku J Exp Med. 1989 Apr;157(4):337-43. PubMed

Suzuki M, Tabuchi M, Ikeda M, Umegaki K, Tomita T. Green tea catechins and cerebral ischemic damage. Med Sci Monit. 2004 Jun;10(6):BR166-74.

Bastianetto S, Yao ZX, Papadopoulos V, Quirion R. Neuroprotection of green and black teas and their catechin gallate esters against beta-amyloid-induced toxicity. Eur J Neurosci. 2006 Jan;23(1):55-64. PubMed

Kuriyama S, Hozawa A, Ohmori K, Shimazu T, Matsui T, Ebihara S, Awata S, Nagatomi R, Arai H, Tsuji I. Green tea consumption and cognitive function. Am J Clin Nutr. 2006 Feb;83(2):355-61.

Shindoh C, DiMarco A, Thomas A, Manubay P, and Supinski G. Effect of N-acetylcysteine on diaphragm fatigue. J Appl Physiol 68: 2107–2113, 1990.

Singh H, Beckman K, and Poulos A. Peroxisomal β-oxidation of branched chain fatty acids in rat liver. Evidence that carnitine palmitoyltransferase I prevents transport of branched chain fatty acids into mitochondria. J Biol Chem 269: 9514–9520, 1994.

Shiota S, Shimizu M, Mizushima T, Ito H, Hatano T, Yoshida T, and Tsuchiya T. Marked reduction in the minimum inhibitory concentration (MIC) of β-lactams in methicillin-resistant Staphylococcus aureus produced by epicatechin gallate, an ingredient of green tea (Camellia sinensis). Biol Pharm Bull 22: 1388–1390, 1999.

Stremmel W, Pohl L, Ring A, and Herrmann T. A new concept of cellular uptake and intracellular trafficking of long-chain fatty acids. Lipids 36: 981–989, 2001.

Graham HN. Green tea composition, consumption, and polyphenol chemistry. Prev Med 1992;21:334–50.

Nakagawa K, Miyazawa T. Absorption and distribution of tea catechin, (-)-epigallocatechin-3-gallate, in the rat. J Nutr Sci Vitaminol (Tokyo) 1997;43:679–84.

Yoshino K, Hara Y, Sano M, Tomita I. Antioxidative effects of black tea theaflavins and thearubigin on lipid peroxidation of rat liver homogenates induced by tert-butyl hydroperoxide. Biol Pharm Bull 1994;17:146–9.

Nakayama M, Suzuki K, Toda M, Okubo S, Hara Y, Shimamura T. Inhibition of the infectivity of influenza virus by tea polyphenols. Antiviral Res 1993;21:289–99.

Hattori M, Kusumoto IT, Namba T, Ishigami T, Hara Y. Effect of tea polyphenols on glucan synthesis by glucosyltransferase from Streptococcus mutans. Chem Pharm Bull 1990;38:717–20.

Katiyar SK, Mukhtar H. Tea in chemoprevention of cancer: epidemiologic and experimental studies. Int J Oncol 1996;8:221–38.

Henry JP, Stephens-Larson P. Reduction of chronic psychosocial hypertension in mice by decaffeinated tea. Hypertension 1984;6:437–44.

Matsumoto N, Ishigaki F, Ishigaki A, Iwashin H, Hara Y. Reduction of blood glucose levels by tea catechin. Biosci Biotech Biochem 1993;57:525–7.

Nanjo F, Hara Y, Kikuchi Y. Effects of tea polyphenols on blood rheology in rats fed a high-fat diet. In: Ho CT, ed. Food phytochemicals for cancer prevention: teas, spices and herbs. Washington, DC: American Chemical Society, 1994:76–82.

Chan PT, Fong WP, Cheung YL, Huang Y, Ho WKK, Chen ZY. Jasmine green tea epicatechins are hypolipidemic in hamsters (Mesocricetus auratus) fed a high fat diet. J Nutr 1999;129:1094–101.

Chaudhari PN, Hatwalne VG. Effect of epicatechin on liver lipids of rats fed with choline deficient diet. Ind J Nutr Diet 1977;14:136–9.

Ishigaki A, Tonooka F, Matsumoto N, Hara Y. Suppression of the accumulation of body and liver fat by tea catechin. Shizuoka, Japan: Organizing Committee of International Symposium on Tea Science, 1991:309–13.

Dulloo AG, Seydoux J, Girardier L, Chantre P, Vandermander J. Green tea and thermogenesis: interactions between catechin-polyphenols, caffeine and sympathetic activity. Int J Obes Relat Metab Disord 2000;24:252–8.

Dulloo AG, Duret C, Rohrer D, et al. Efficacy of a green tea extract rich in catechin polyphenols and caffeine in increasing 24-h energy expenditure and fat oxidation in humans. Am J Clin Nutr 1999;70:1040–5.

Rumpler W, Seale J, Clevidence B, et al. Oolong tea increases metabolic rate and fat oxidation in men. J Nutr 2001;131:2848–52.

Chantre P, Lairon D. Recent findings of green tea extract AR25 (Exolise) and its activity for the treatment of obesity. Phytomedicine 2002;9:3–8.

Van Gaal LF, Vertommen J, De Leeuw IH. The in vitro oxidizability of lipoprotein particles in obese and non-obese subjects. Atherosclerosis 1998;137:S39–44.

Prazny M, Skrha J, Hilgertova J. Plasma malondialdehyde and obesity: is there a relationship? Clin Chem Lab Med 1999;37:1129–30.

Sawa H. Outline of research activitites of the National Institute of Health and Nutrition. Outline of research activities in 1999. Internet: http://www.nih.go.jp/eiken/english/research/pdf/nenpo99_e.pdf (accessed 18 July 2002).

Standard tables of food composition in Japan 2000. 4th ed. Tokyo: Kagawa Nutrition University Publishing Division, 2000:417–9 (in Japanese).

The new calorie guide book for daily diet. Tokyo: Kagawa Nutrition University Publishing Division, 2002 (in Japanese).

The National Nutrition Survey, Japan in 1998. Tokyo: Dai-ichi Shuppan Publishing Co Ltd, 2000:65 (in Japanese).

Tokunaga K, Matsuzawa Y, Ishikawa K, Tarui S. A novel technique for the determination of body fat by computed tomography. Int J Obes 1983;7:437–45.

Vitamins. In: Henry R, Cannon D, Winkelman J. eds. Clinical chemistry: principles and technics. 2nd ed. New York: Harper & Row, 1974:1374–81.

Abe K, Katsui G. Fluorometric determination of tocopherol in serum. J Jpn Soc Nutr Food 1975;28:277–80 (in Japanese).

Kotani K, Maekawa M, Kanno T, Kondo A, Toda N, Manabe M. Distribution of immunoreactive malondialdehyde-modified low-density lipoprotein in human serum. Biochim Biophys Acta 1994;1215:121–5.

Connerty HV, Briggs AR. Determination of serum calcium by means of orthocresolphthalein complexone. Am J Clin Pathol 1966;45:290–6.

Drewes PA. Direct colorimetric determination of phosphorus in serum and urine. Clin Chim Acta 1972;39:81–8.

Kuwa K. Ion selective electrode. J Med Technol 1990;34:1353–8 (in Japanese).

Standard tables of food composition in Japan 2000. 4th ed. Tokyo: Kagawa Nutrition University Publishing Division, 2000:410 (in Japanese).

SRL.info. Tokyo: SRL, Inc. Internet: http://www.srl.info/srlinfo/kensa_ref_CD/index.htm (accessed 30 October 2001).

Fancy drink. In: 2001 Food marketing handbook. Tokyo: Fuji Keizai Co, Ltd, 2001:89–97 (in Japanese).

Nakagawa K, Okuda S, Miyazawa T. Dose-dependent incorporation of tea catechins, (-)-epigallocatechin-3-gallate and (-)-epigallocatechin, into human plasma. Biosci Biotechnol Biochem 1997;61:1981–5.

Borchardt RT, Huber JA. Catechol O-methyltransferase. 5. Structure-activity relationships for inhibition by flavonoids. J Med Chem 1975;18:120–2.

Yla-Herttuala S, Palinski W, Rosenfeld ME, et al. Evidence for the presence of oxidatively modified low density lipoprotein in atherosclerotic lesions of rabbit and man. J Clin Invest 1989;84:1086–95.

Holvoet P, Perez G, Zhao Z, et al. Malondialdehyde-modified low density lipoproteins in patients with atherosclerotic disease. J Clin Invest 1995;95:2611–9.

Beier K, Volkl A, Fahimi D. TNF-alpha downregulates the peroxisome proliferator activated receptor-alpha and the mRNAs encoding peroxisomal proteins in rat liver. FEBS Lett 1997;412:385–7.

Parmentier JH, Schohn H, Bronner M, et al. Regulation of CYP4A1 and peroxisome proliferator-activated receptor alpha expression by interleukin-1 beta, interleukin-6, and dexamethasone in cultured fetal rat hepatocytes. Biochem Pharmacol 1997;54:889–98.

Neve BP, Fruchart JC, Staels B. Role of the peroxisome proliferator-activated receptors (PPAR) in atherosclerosis. Biochem Pharmacol 2000;60:1245–50.

Poynter ME, Daynes RA. Peroxisome proliferator-activated receptor alpha activation modulates cellular redox status, represses nuclear factor-kappa B signaling, and reduces inflammatory cytokine production in aging. J Biol Chem 1998;273:32833–41.

Muramatsu K, Fukuyo M, Hara Y. Effect of green tea catechins on plasma cholesterol level in cholesterol-fed rats. J Nutr Sci Vitaminol (Tokyo) 1986;32:613–22.

Ikeda I, Imasato Y, Sasaki E, et al. Tea catechins decrease micellar solubility and intestinal absorption of cholesterol in rats. Biochim Biophys Acta 1992;1127:141–6.

Nagao T, Hase T, Tokimitsu I. A green tea extract high in catechins reduces body fat and cardiovascular risks in humans. Obesity (Silver Spring). 2007;15(6):1473-83.

Narotzki B, Reznick AZ, Aizenbud D, Levy Y. Green tea: a promising natural product in oral health. Arch Oral Biol. 2012; 57(5):429-35.

Pazyar N, Feily A, Kazerouni A. Green tea in dermatology. Skinmed. 2012; 10(6):352-5.

Peters U, Poole C, Arab L. Does tea affect cardiovascular disease? A meta-analysis. Am J Epidemiol. 2001;154(6):495-503.

Rowe CA, Nantz MP, Bukowski JF, Percival SS. Specific formulation of Camellia sinensis prevents cold and flu symptoms and enhances gammadelta T cell function: a randomized, double-blind, placebo-controlled study. J Am Coll Nutr. 2007;26(5):445-52.

Ryu OH, Lee J, Lee KW, et al. Effects of green tea consumption on inflammation, insulin resistance and pulse wave velocity in type 2 diabetes patients. Diabetes Res Clin Pract. 2006;71(3):356-8.

Sano T, Sasako M. Green tea and gastric cancer. N Engl J Med. 2001;344(9):675-676.

Sasazuki S, Kodama H, Yoshimasu K et al. Relation between green tea consumption and the severity of coronary atherosclerosis among Japanese men and women. Ann Epidemiol. 2000;10:401-408.

Setiawan VW, Zhang ZF, Yu GP, et al. Protective effect of green tea on the risks of chronic gastritis and stomach cancer. Int J Cancer. 2001;92(4):600-604.

Shankar S, Ganapathy S, Hingorani SR, Srivastava RK. EGCG inhibits growth, invasion, angiogenesis and metastasis of pancreatic cancer. Front Biosci. 2008;13:440-52.

Steptoe A, Gibson EL, Vuonovirta R, Hamer M, Wardle J, Rycroft JA, Martin JF, Erusalimsky JD. The effects of chronic tea intake on platelet activation and inflammation: a double-blind placebo controlled trial. Atherosclerosis. 2007;193(2):277-82.

Vinson JA, Teufel K, Wu N. Green and black teas inhibit atherosclerosis by lipid, antioxidant, and fibrinolytic mechanisms. J Agric Food Chem. 2004;52(11):3661-5.

Wargovich MJ, Woods C, Hollis DM, Zander ME. Herbals, cancer prevention and health. [Review]. J Nutr. 2001;131(11 Suppl):3034S-3036S.

Suzuki Y, Tsubono Y, Nakaya N, Suzuki Y, Koizumi Y, Tsuji I. Green tea and the risk of breast cancer: pooled analysis of two prospective studies in Japan. Br J Cancer. Apr 5, 2004;90(7)1361-1363.

Thatte U, Bagadey S, Dahanukar S. Modulation of programmed cell death by medicinal plants. [Review]. Cell Mol Biol. 2000;46(1):199-214.

Thavanesan N. The putative effects of green tea on body fat: an evaluation of the evidence and a review of the potential mechanisms. Br J Nutr. 2011 Aug 3:1-13. [Epub ahead of print]

Trudel D, Labbe DP, Bairati I, Fradet V, Bazinet L, Tetu B. Green tea for ovarian cancer prevention and treatment: a systemic review of the in vitro, in vivo and epidemiological studies. Gynecol Oncol. 2012; 126(3):491-8.

Tsubono Y, Nishino Y, Komatsu S, et al. Green tea and the risk of gastric cancer in Japan. N Engl J Med. 2001;344(9):632-636.

Westerterp-Plantenga MS, Lejeune MP, Kovacs EM. Body weight and weight maintenance in relation to habitual caffeine intake and green tea. Obes Res Jul 2005;13(7):1195-1204.

Wu AH, Butler LM. Green tea and breast cancer. Mol Nutr Food Res. 2011 Jun;55(6):921-30.

Yang G, Shu XO, Li H, Chow WH, Ji BT, Zhang X, Gao YT, Zheng W. Prospective cohort study of green tea consumption and colorectal cancer risk in women. Cancer Epidemiol Biomarkers Prev. 2007;16(6):1219-23.

Zheng J, Yang B, Huang T, Yu Y, Yang J, Li D. Green tea and black tea consumption and prostate cancer risk: an exploratory meta-analysis of observational studies. Nutr Cancer. 2011;63(5):663-72. Epub 2011 Jun 11.

Zheng XX, Xu YL, Li SH, Liu XX, Hui R, Huang XH. Green tea intake lowers fasting serum total and LDL cholesterol in adults: a meta-analysis of 14 randomized controlled trials. Am J Clin Nutr. 2011; 94(2):601-10.

Zhou B, Yang L, Wang L, Shi Y, Zhu H, Tang N, Wang B. The association of tea consumption with ovarian cancer risk: a meta-analysis. Am J Obstet Gynecol. 2007;197(6):594.e1-6.

Yang G, Zheng W, Xiang YB, Gao J, Li HL, Zhang X, Gao YT, Shu XO. Green tea consumption and colorectal cancer risk: a report from the Shanghai Men’s Health Study. Carcinogenesis. 2011 Sep 8. [Epub ahead of print]

Yuan JM. Green tea and prevention of esophageal and lung cancers. Mol Nutr Food Res. 2011 Jun;55(6):886-904.

Zhang M, Lee AH, Binns CW, Xie X. Green tea consumption enhances survival of epithelial ovarian cancer. Int J Cancer Nov 10, 2004;112(3):465-469.

Coimbra S, Santos-Silva A, Rocha-Pereira P, Rocha S, Castro E. Green tea consumption improves plasma lipid profiles in adults. Nutr Res. 2006 Nov;26(11):604-7. 2006.

Devine A, Hodgson JM, Dick IM, Prince RL. Tea drinking is associated with benefits on bone density in older women. Am J Clin Nutr. 2007 Oct;86(4):1243-7. 2007. PMID:17921409.

Donovan JL, Chavin KD, Devane CL, Taylor RM, Wang JS, Ruan Y, Markowitz JS. Green tea (Camellia sinensis) extract does not alter cytochrome p450 3A4 or 2D6 activity in healthy volunteers. Drug Metab Dispos. 2004 Sep;32(9):906-8. 2004. PMID:15319329.

Adhami VM, Siddiqui IA, Ahmad N, Gupta S, Mukhtar H. Oral consumption of green tea polyphenols inhibits insulin-like growth factor-I-induced signaling in an autochthonous mouse model of prostate cancer. Cancer Res. 2004 Dec 1;64(23):8715-22. 2004. PMID:15574782.

Aneja R, Hake PW, Burroughs TJ, Denenberg AG, Wong HR, Zingarelli B. Epigallocatechin, a green tea polyphenol, attenuates myocardial ischemia reperfusion injury in rats. Mol Med. 2004 Jan-Jun;10(1-6):55-62. 2004. PMID:15502883.

Azam S, Hadi N, Khan NU, Hadi SM. Prooxidant property of green tea polyphenols epicatechin and epigallocatechin-3-gallate: implications for anticancer properties. Toxicol In Vitro. 2004 Oct;18(5):555-61. 2004. PMID:15251172.

Baek SJ, Kim JS, Jackson FR, Eling TE, McEntee MF, Lee SH. Epicatechin gallate-induced expression of NAG-1 is associated with growth inhibition and apoptosis in colon cancer cells. Carcinogenesis. 2004 Aug 12; [Epub ahead of print]. 2004. PMID:15308587.

Bastianetto S, Yao ZX, Papadopoulos V, Quirion R. Neuroprotective effects of green and black teas and their catechin gallate esters against beta-amyloid-induced toxicity. Eur J Neurosci. 2006 Jan;23(1):55-64. 2006. PMID:16420415.

BBC Health News. Green tea ‘may protect the heart. 2005/02/28, http://news.bbc.co.uk/go/pr/fr/-/1/hi/health/4298403.stm. 2005.

Chen D, Daniel KG, Kuhn DJ, Kazi A, Bhuiyan M, Li L, Wang Z, Wan SB, Lam WH, Chan TH, Dou QP. Green tea and tea polyphenols in cancer prevention. Front Biosci. 2004 Sep 01;9:2618-31. 2004. PMID:15358585.

Chen JH, Tipoe GL, Liong EC, So HS, Leung KM, Tom WM, Fung PC, Nanji AA. Green tea polyphenols prevent toxin-induced hepatotoxicity in mice by down-regulating inducible nitric oxide-derived prooxidants. Am J Clin Nutr. 2004 Sep;80(3):742-51. 2004. PMID:15321817.

Choi YB, Kim YI, Lee KS, Kim BS, Kim DJ. Protective effect of epigallocatechin gallate on brain damage after transient middle cerebral artery occlusion in rats. Brain Res. 2004 Sep 3;1019(1-2):47-54. 2004. PMID:15306237.

Eckert RL, Crish JF, Efimova T, Balasubramanian S. Antioxidants regulate normal human keratinocyte differentiation. Biochem Pharmacol. 2004 Sep 15;68(6):1125-31. 2004. PMID:15313409.

Lodi G , Sardella A , Bez C , Demarosi F , Carrassi A . Interventions for treating oral leukoplakia . Cochrane Database Syst Rev . 2004;(3):CD001829.

Lambert JD , Yang CS . Cancer chemopreventive activity and bioavailability of tea and tea polyphenols . Mutat Res . 2003;523-524:201-208.

Ensminger AH, Ensminger, ME, Kondale JE, Robson JRK. Foods & Nutriton Encyclopedia. Pegus Press, Clovis, California. 1983.

Fassina G, Vene R, Morini M, Minghelli S, Benelli R, Noonan DM, Albini A. Mechanisms of inhibition of tumor angiogenesis and vascular tumor growth by epigallocatechin-3-gallate. Clin Cancer Res. 2004 Jul 15;10(14):4865-73. 2004. PMID:15269163.

Gouni-Berthold I, Sachinidis A. Molecular mechanisms explaining the preventive effects of catechins on the development of proliferative diseases. Curr Pharm Des. 2004;10(11):1261-71. 2004. PMID:15078140.

Hakim IA, Harris RB, Chow HH, Dean M, Brown S, Ali IU. Effect of a 4-month tea intervention on oxidative DNA damage among heavy smokers: role of glutathione S-transferase genotypes. Cancer Epidemiol Biomarkers Prev. 2004 Feb;13(2):242-9. 2004. PMID:14973088.

Han YS, Bastianetto S, Dumont Y, Quirion R. Specific plasma membrane binding sites for polyphenols, including resveratrol, in the rat brain. J Pharmacol Exp Ther. 2006 Mar 30; [Epub ahead of print]. 2006. PMID:16574779.

Haque AM, Hashimoto M, Katakura M, Tanabe Y, Hara Y, Shido O. Long-term administration of green tea catechins improves spatial cognition learning ability in rats. J Nutr. 2006 Apr;136(4):1043-7. 2006. PMID:16549472.

Huh SW, Bae SM, Kim YW, Lee JM, Namkoong SE, Lee IP, Kim SH, Kim CK, Ahn WS. Anticancer effects of (-)-epigallocatechin-3-gallate on ovarian carcinoma cell lines. Gynecol Oncol. 2004 Sep;94(3):760-8. 2004. PMID:15350370.

Hussain T, Gupta S, Adhami VM, Mukhtar H. Green tea constituent epigallocatechin-3-gallate selectively inhibits COX-2 without affecting COX-1 expression in human prostate carcinoma cells. Int J Cancer. 2004 Sep 28; [Epub ahead of print]. 2004. PMID:15455372.

Ikeda I, Tsuda K, Suzuki Y, Kobayashi M, Unno T, Tomoyori H, Goto H, Kawata Y, Imaizumi K, Nozawa A, Kakuda T. Tea catechins with agalloyl moiety suppress postprandial hypertriacylglycerolemia by delaying lymphatic transport of dietary fat in rats. J Nutr. 2005 Feb;135(2):155-9. 2005. PMID:15671206.

Irwin K. Green tea extract has potential as an anti-cancer agent, according to a study by UCLA researchers. UCLA News, February 15, 2005. 2005.

Jian L, Lee AH, Binns CW. Tea and lycopene protect against prostate cancer. Asia Pac J Clin Nutr. 2007;16 Suppl 1:453-7. 2007. PMID:17392149.

Ju J, Liu Y, Hong J, Huang MT, Conney AH, Yang CS. Effects of green tea and high-fat diet on arachidonic acid metabolism and aberrant crypt foci formation in an azoxymethane-induced colon carcinogenesis mouse model. Nutr Cancer. 2003;46(2):172-8. 2003. PMID:14690793.

Juhel C, Armand M, Pafumi Y, Rosier C, Vandermander J, Lairon D. Green tea extract (AR25(R)) inhibits lipolysis of triglycerides in gastric and duodenal medium in vitro. J Nutr Biochem. 2000 Jan;11(1):45-51. 2000. PMID:15539342.

Kim DW, Park YS, Kim YG, Piao H, Kwon JS, Hwang KK, Youn TJ, Park JB, Yun YP, Sachinidis A, Kim CH, Cho MC, Ahn HY. Local delivery of green tea catechins inhibits neointimal formation in the rat carotid artery injury model. Heart Vessels. 2004 Sep;19(5):242-7. 2004. PMID:15372300.

Koo MW, Cho CH. Pharmacological effects of green tea on the gastrointestinal system. Eur J Pharmacol. 2004 Oct 1;500(1-3):177-85. 2004. PMID:15464031.

Koyama Y, Abe K, Sano Y, Ishizaki Y, Njelekela M, Shoji Y, Hara Y, Isemura M. Effects of Green Tea on Gene Expression of Hepatic Gluconeogenic Enzymes in vivo. Planta Med. 2004 Nov;70(11):1100-1102. 2004. PMID:15549673.

Kurahashi N, Sasazuki S, Iwasaki M, Inoue M; Shoichiro Tsugane for the JPHC Study Group. Green Tea Consumption and Prostate Cancer Risk in Japanese Men: A Prospective Study. Am J Epidemiol. 2007 Sep 29; [Epub ahead of print] . 2007. PMID:17906295.

Kuriyama S, Hozawa A, Ohmori K, Shimazu T, Matsui T, Ebihara S, Awata S, Nagatomi R, Arai H, Tsuji I. Green tea consumption and cognitive function: a cross-sectional study from the Tsurugaya Project 1. Am J Clin Nutr. 2006 Feb;83(2):355-61. 2006. PMID:16469995.

Kuriyama S, Shimazu T, Ohmori K, Kikuchi N, Nakaya N, Nishino Y, Tsubono Y, Tsuji I. Green tea consumption and mortality due to cardiovascular disease, cancer, and all causes in Japan: the Ohsaki study. JAMA. 2006 Sep 13;296(10):1255-65. 2006. PMID:16968850.

Lambert JD, Hong J, Kim DH, Mishin VM, Yang CS. Piperine enhances the bioavailability of the tea polyphenol (-)-epigallocatechin-3-gallate in mice. J Nutr. 2004 Aug;134(8):1948-52. 2004. PMID:15284381.

Larsson SC, Wolk A. Tea consumption and ovarian cancer risk in a population-based cohort. Arch Intern Med. 2005 Dec 12-26;165(22):2683-6. 2005. PMID:16344429.

Levites Y, Amit T, Youdim MB, Mandel S. Involvement of protein kinase C activation and cell survival/ cell cycle genes in green tea polyphenol (-)-epigallocatechin 3-gallate neuroprotective action. J Biol Chem. 2002 Aug 23;277(34):30574-80. 2002. PMID:12058035.

Ullmann U , Haller J , Decourt JD , Girault J , Spitzer V , Weber P . Plasma-kinetic characteristics of purified and isolated green tea catechin epigallocatechin gallate (EGCG) after 10 days repeated dosing in healthy volunteers . Int J Vitam Nutr Res . 2004;74(4):269-278.

Mazzanti G, Menniti-Ippolito F, Moro PA, et al. Hepatotoxicity from green tea: a review of the literature and two unpublished cases. Eur J Clin Pharmacol . 2009;65(4):331-341.

Gardner EJ, Ruxton CH, Leeds AR. Black tea – helpful or harmful? A review of the evidence. Eur J Clin Nutr. 2006 Jul 19; [Epub ahead of print] . 2006. PMID:16855537.

Gates MA, Tworoger SS, Hecht JL, De Vivo I, Rosner B, Hankinson SE. A prospective study of dietary flavonoid intake and incidence of epithelial ovarian cancer. Int J Cancer. 2007 Apr 30; [Epub ahead of print]. 2007. PMID:17471564.

Geetha T, Garg A, Chopra K, Pal Kaur I. Delineation of antimutagenic activity of catechin, epicatechin and green tea extract. Mutat Res. 2004 Nov 22;556(1-2):65-74. 2004. PMID:15491633.

Belza A, Toubro S, Astrup A. The effect of caffeine, green tea and tyrosine on thermogenesis and energy intake. Eur J Clin Nutr . 2009;63(1):57-64.

Shen CL, Yeh JK, Cao JJ, Wang JS. Green tea and bone metabolism [published correction appears in Nutr Res . 2009;29(9):684]. Nutr Res . 2009;29(7):437-456.

Ghosh KS, Maiti TK, Dasgupta S. Green tea polyphenols as inhibitors of ribonuclease A. Biochem Biophys Res Commun. 2004 Dec 17;325(3):807-11. 2004. PMID:15541362.

Liu YJ, Pan BS. Inhibition of fish gill lipoxygenase and blood thinning effects of green tea extract. J Agric Food Chem. 2004 Jul 28;52(15):4860-4. 2004. PMID:15264926.

Lorenz M, Jochmann N, von Krosigk A, Martus P, Baumann G, Stangl K, Stangl V. Addition of milk prevents vascular protective effects of tea. Eur Heart J. 2007 Jan;28(2):219-23. Epub 2007 Jan 9. 2007. PMID:17213230.

Lu QY, Jin YS, Pantuck A, Zhang ZF, Heber D, Belldegrun A, Brooks M, Figlin R, Rao J. Green tea extract modulates actin remodeling via Rho activity in an in vitro multistep carcinogenic model. Clin Cancer Res. 2005 Feb 15;11(4):1675-83. 2005. PMID:15746073.

Mandel S, Youdim MB. Catechin polyphenols: neurodegeneration and neuroprotection in neurodegenerative diseases. Free Radic Biol Med. 2004 Aug 1;37(3):304-17. 2004. PMID:15223064.

Mei Y, Qian F, Wei D, Liu J. Reversal of cancer multidrug resistance by green tea polyphenols. J Pharm Pharmacol. 2004 Oct;56(10):1307-14. 2004. PMID:15482646.

Mittal A, Pate MS, Wylie RC, Tollefsbol TO, Katiyar SK. EGCG down-regulates telomerase in human breast carcinoma MCF-7 cells, leading to suppression of cell viability and induction of apoptosis. Int J Oncol. 2004 Mar;24(3):703-10. 2004. PMID:14767556.

Mohamadin AM, El-Beshbishy HA, El-Mahdy MA. Green tea extract attenuates cyclosporine A-induced oxidative stress in rats. Pharmacol Res. 2005 Jan;51(1):51-7. 2005. PMID:15519535.

Muraki S, Yamamoto S, Oka H, Yoshimura N, Kawaguchi, H, Orimo H, Nakamura K. Green tea drinking is associated with increased bone mineral density in elderly women. Study P187SA, presented at the International Osteoporosis Foundation World Congress on Osteoporosis, Toronto, Canada, June 5, 2006. 2006.

Murase T, Haramizu S, Shimotoyodome A, Nagasawa A, Tokimitsu I. Green tea extract improves endurance capacity and increases muscle lipid oxidation in mice. Am J Physiol Regul Integr Comp Physiol. 2004 Nov 24; [Epub ahead of print]. 2004. PMID:15563575.

Nagao T, Komine Y, Soga S, Meguro S, Hase T, Tanaka Y, Tokimitsu I. Ingestion of a tea rich in catechins leads to a reduction in body fat and malondialdehyde-modified LDL in men. Am J Clin Nutr. 2005 Jan;81(1):122-9. 2005. PMID:15640470.

Niwattisaiwong N, Luo XX, Coville PF, Wanwimolruk S. Effects of Chinese, Japanese and Western tea on hepatic P450 enzyme activities in rats. Drug Metabol Drug Interact. 2004;20(1-2):43-56. 2004. PMID:15283302.

Ostrowska J, Luczaj W, Kasacka I, Rozanski A, Skrzydlewska E. Green tea protects against ethanol-induced lipid peroxidation in rat organs. Alcohol. 2004 Jan;32(1):25-32. 2004. PMID:15066700.

Ouyang P, Peng WL, Lai WY, Xu AL. [Green tea polyphenols inhibit low-density lipoprotein-induced proliferation of rat vascular smooth muscle cells]. Di Yi Jun Yi Da Xue Xue Bao. 2004 Sep;24(9):975-9. 2004. PMID:15447839.

Ouyang P, Peng WL, Xu DL, Lai WY, Xu AL. Green tea polyphenols inhibit advanced glycation end product-induced rat vascular smooth muscle cell proliferation. Di Yi Jun Yi Da Xue Xue Bao. 2004 Mar;24(3):247-51. 2004. PMID:15041533.

Camouse MM, Domingo DS, Swain FR, et al. Topical application of green and white tea extracts provides protection from solar-simulated ultraviolet light in human skin. Exp Dermatol . 2009;18(6):522-526.

Janjua R, Munoz C, Gorell E, et al. A two-year, double-blind, randomized placebo-controlled trial of oral green tea polyphenols on the long-term clinical and histologic appearance of photoaging skin. Dermatol Surg . 2009;35(7):1057-1065.

Park HJ, Shin DH, Chung WJ, Leem K, Yoon SH, Hong MS, Chung JH, Bae JH, Hwang JS. Epigallocatechin gallate reduces hypoxia-induced apoptosis in human hepatoma cells. Life Sci. 2006 Jan 26; [Epub ahead of print]. 2006. PMID:16445947.

Pezzato E, Sartor L, Dell’Aica I, Dittadi R, Gion M, Belluco C, Lise M, Garbisa S. Prostate carcinoma and green tea: PSA-triggered basement membrane degradation and MMP-2 activation are inhibited by (-)epigallocatechin-3-gallate. Int J Cancer. 2004 Dec 10;112(5):787-92. 2004. PMID:15386386.

Reznichenko L, Amit T, Zheng H, Avramovich-Tirosh Y, Youdim MB, Weinreb O, Mandel S. Reduction of iron-regulated amyloid precursor protein and beta-amyloid peptide by (-)-epigallocatechin-3-gallate in cell cultures: implications for iron chelation in Alzheimer’s disease. J Neurochem. 2006 Mar 15; [Epub ahead of print]. 2006. PMID:16539659.

Navarro-Peran E, Cabezas-Herrera J, Garcia-Canovas F, Durrant MC, Thorneley RN, Rodriguez-Lopez JN. The antifolate activity of tea catechins. Cancer Res. 2005 Mar 15;65(6):2059-64. 2005. PMID:15781612.

Negishi H, Xu JW, Ikeda K, Njelekela M, Nara Y, Yamori Y. Black and green tea polyphenols attenuate blood pressure increases in stroke-prone spontaneously hypertensive rats. J Nutr. 2004 Jan;134(1):38-42. 2004. PMID:14704290.

Sakanaka S, Okada Y. Inhibitory effects of green tea polyphenols on the production of a virulence factor of the periodontal-disease-causing anaerobic bacterium Porphyromonas gingivalis. J Agric Food Chem. 2004 Mar 24;52(6):1688-92. 2004. PMID:15030231.

Saleem M, Adhami VM, Siddiqui IA, Mukhtar H. Tea beverage in chemoprevention of prostate cancer: a mini-review. Nutr Cancer. 2003;47(1):13-23. 2003. PMID:14769533.

Sano J, Inami S, Seimiya K, Ohba T, Sakai S, Takano T, Mizuno K. Effects of green tea intake on the development of coronary artery disease. Circ J. 2004 Jul;68(7):665-70. 2004. PMID:15226633.

Sartippour MR, Heber D, Henning S, Elashoff D, Elashoff R, Rubio R, Zhang L, Norris A, Brooks MN. cDNA microarray analysis of endothelial cells in response to green tea reveals a suppressive phenotype. Int J Oncol. 2004 Jul;25(1):193-202. 2004. PMID:15202006.

Sasazuki S, Kodama H, et al. Relation between green tea consumption and the severity of coronary atherosclerosis among Japanese men and women. Ann Epidemiol 2000 Aug;10(6):401-8. 2000.

Schwartz JL, Baker V, Larios E, Chung FL. Molecular and cellular effects of green tea on oral cells of smokers: A pilot study. Mol Nutr Food Res. 2004 Nov 11; [Epub ahead of print]. 2004. PMID:15538715.

Shirai N, Suzuki H. Effects of Western, Vegetarian, and Japanese dietary fat model diets with or without green tea extract on the plasma lipids and glucose, and liver lipids in mice. A long-term feeding experiment. Ann Nutr Metab. 2004;48(2):95-102. Epub 2004 Feb 25. 2004. PMID:14988639.

Siddiqui IA, Afaq F, Adhami VM, Ahmad N, Mukhtar H. Antioxidants of the beverage tea in promotion of human health. Antioxid Redox Signal. 2004 Jun;6(3):571-82. 2004. PMID:15130283.

Son DJ, Cho MR, Jin YR, Kim SY, Park YH, Lee SH, Akiba S, Sato T, Yun YP. Antiplatelet effect of green tea catechins: a possible mechanism through arachidonic acid pathway. Prostaglandins Leukot Essent Fatty Acids. 2004 Jul;71(1):25-31. 2004. PMID:15172681.

Song JM, Lee KH, Seong BL. Antiviral effect of catechins in green tea on influenza virus. Antiviral Res. 2005 Nov;68(2):66-74. Epub 2005 Aug 9. 2005. PMID:16137775.

Stephanou A. Role of STAT-1 and STAT-3 in ischaemia/reperfusion injury. J Cell Mol Med. 2004 Oct-Dec;8(4):519-25. 2004. PMID:15601580.

Sugiyama T, Sadzuka Y. Theanine, a specific glutamate derivative in green tea, reduces the adverse reactions of doxorubicin by changing the glutathione level. Cancer Lett. 2004 Aug 30;212(2):177-84. 2004. PMID:15279898.

Sun CL, Yuan JM, Koh WP, Yu MC. Green tea, black tea and breast cancer risk: a meta-analysis of epidemiological studies. Carcinogenesis. 2006 Jul;27(7):1310-5. 2006. PMID:16855537.

Suzuki M, Tabuchi M, Ikeda M, Umegaki K, Tomita T. Protective effects of green tea catechins on cerebral ischemic damage. Med Sci Monit. 2004 Jun;10(6):BR166-74. 2004. PMID:15173662.

Tian WX, Li LC, Wu XD, Chen CC. Weight reduction by Chinese medicinal herbs may be related to inhibition of fatty acid synthase. Life Sci. 2004 Mar 26;74(19):2389-99. 2004. PMID:14998716.

Townsend PA, Scarabelli TM, Pasini E, Gitti G, Menegazzi M, Suzuki H, Knight RA, Latchman DS, Stephanou A. Epigallocatechin-3-gallate inhibits STAT-1 activation and protects cardiac myocytes from ischemia/reperfusion-induced apoptosis. FASEB J. 2004 Oct;18(13):1621-3. 2004. PMID:15319365.

Tsuneki H, Ishizuka M, Terasawa M, Wu JB, Sasaoka T, Kimura I. Effect of green tea on blood glucose levels and serum proteomic patterns in diabetic (db/db) mice and on glucose metabolism in healthy humans. BMC Pharmacol. 2004 Aug 26;4(1):18. 2004. PMID:15331020.

Unno K, Takabayashi F, Kishido T, Oku N. Suppressive effect of green tea catechins on morphologic and functional regression of the brain in aged mice with accelerated senescence (SAMP10). Exp Gerontol. 2004 Jul;39(7):1027-34. 2004. PMID:15236762.

Vinson JA, Teufel K, Wu N. Green and black teas inhibit atherosclerosis by lipid, antioxidant, and fibrinolytic mechanisms. J Agric Food Chem. 2004 Jun 2;52(11):3661-5. 2004. PMID:15161246.

Weinreb O, Mandel S, Amit T, Youdim MB. Neurological mechanisms of green tea polyphenols in Alzheimer’s and Parkinson’s diseases. J Nutr Biochem. 2004 Sep;15(9):506-16. 2004. PMID:15350981.

Wu LY, Juan CC, Ho LT, Hsu YP, Hwang LS. Effect of green tea supplementation on insulin sensitivity in Sprague-Dawley rats. J Agric Food Chem. 2004 Feb 11;52(3):643-8. 2004. PMID:14759162.

Wu LY, Juan CC, Hwang LS, Hsu YP, Ho PH, Ho LT. Green tea supplementation ameliorates insulin resistance and increases glucose transporter IV content in a fructose-fed rat model. Eur J Nutr. 2004 Apr;43(2):116-24. 2004. PMID:15083319.

Yang G, Shu XO, Li H, Chow WH, Ji BT, Zhang X, Gao YT, Zheng W. Prospective cohort study of green tea consumption and colorectal cancer risk in women. Cancer Epidemiol Biomarkers Prev. 2007 Jun;16(6):1219-23. 2007. PMID:17548688.

Yang YC, Lu FH, Wu JS, Wu CH, Chang CJ. The protective effect of habitual tea consumption on hypertension. Arch Intern Med. 2004 Jul 26;164(14):1534-40. 2004. PMID:15277285.

Ying CJ, Sun XF, Zhang SL, Zhang XP, Mao LM, Zuo XZ, Yao P. ROS-related enzyme expressions in endothelial cells regulated by tea polyphenols. Biomed Environ Sci. 2004 Mar;17(1):33-9. 2004. PMID:15202862.

Yun JH, Pang EK, Kim CS, Yoo YJ, Cho KS, Chai JK, Kim CK, Choi SH. Inhibitory effects of green tea polyphenol (-)-epigallocatechin gallate on the expression of matrix metalloproteinase-9 and on the formation of osteoclasts. J Periodontal Res. 2004 Oct;39(5):300-7. 2004. PMID:15324350.

Zhang M, Lee AH, Binns CW, Xie X. Green tea consumption enhances survival of epithelial ovarian cancer. Int J Cancer. 2004 Nov 10;112(3):465-9. 2004. PMID:15382073.

Zhang XH, Andreotti G, Gao YT, Deng J, Liu E, Rashid A, Wu K, Sun L, Sakoda LC, Cheng JR, Shen MC, Wang BS, Han TQ, Zhang BH, Gridley G, Fraumeni JF Jr, Hsing AW. Tea drinking and the risk of biliary tract cancers and biliary stones: a population-based case-control study in Shanghai, China. Int J Cancer. 2006 Jun 15;118(12):3089-94. 2006. PMID:16395699.

Zheng G, Sayama K, Okubo T, Juneja LR, Oguni I. Anti-obesity effects of three major components of green tea, catechins, caffeine and theanine, in mice. In Vivo. 2004 Jan-Feb;18(1):55-62. 2004. PMID:15011752.

Japanische Teezeremonie und Ökologische Landwirtschaft – Wikipedia.

Iwasaki M, Inoue M, Sasazuki S, et al. Plasma tea polyphenol levels and subsequent risk of breast cancer among Japanese women: A nested case-control study. Breast Cancer Research and Treatment 2010; Epub ahead of print May 4, 2010.

Yang CS, Maliakal P, Meng X. Inhibition of carcinogenesis by tea. Annual Review of Pharmacology and Toxicology 2002; 42:25–54.

Santana-Rios G, Orner GA, Xu M, Izquierdo-Pulido M, Dashwood RH. Inhibition by white tea of 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine-induced colonic aberrant crypts in the F344 rat. Nutrition and Cancer 2001; 41(1 and 2):98–103.

Chen ZY, Zhu QY, Tsang D, Huang Y. Degradation of green tea catechins in tea drinks. Journal of Agricultural and Food Chemistry 2001; 49(1):477–482.

Terada S, Goto M, Kato M, Kawanaka K, Shimokawa T, and Tabata I. Effects of low-intensity prolonged exercise on PGC-1 mRNA expression in rat epitrochlearis muscle. Biochem Biophys Res Commun 296: 350–354, 2002.

Tunstall RJ, Mehan KA, Wadley GD, Collier GR, Bonen A, Hargreaves M, and Cameron-Smith D. Exercise training increases lipid metabolism gene expression in human skeletal muscle. Am J Physiol Endocrinol Metab 283: E66–E72, 2002.

Valet P, Tavernier G, Castan-Laurell I, Saulnier-Blache JS, and Langin D. Understanding adipose tissue development from transgenic animal models. J Lipid Res 43: 835–860, 2002.

Lonn E, Bosch J, Yusuf S, et al. Effects of long-term vitamin E supplementation on cardiovascular events and cancer: a randomized controlled trial. JAMA. 2005; 293:1338–47.

A randomized, placebo-controlled, clinical trial of high-dose supplementation with vitamins C and E and beta-carotene for age-related cataract and vision loss: AREDS report no. 9. Arch Ophthalmol. 2001; 119:1439-52.

Richer S, Stiles W, Statkute L, et al. Double-masked, placebo-controlled, randomized trial of lutein and antioxidant supplementation in the intervention of atrophic age-related macular degeneration: the Veterans LAST study (Lutein Antioxidant Supplementation Trial). Optometry. 2004; 75:216-30.

Bartlett HE, Eperjesi F. Effect of lutein and antioxidant dietary supplementation on contrast sensitivity in age-related macular disease: a randomized controlled trial. Eur J Clin Nutr. 2007; 61:1121-27.

Age Related Eye Disease Study 2 (AREDS2). National Eye Institute.

Albanes D, Heinonen OP, Taylor PR, et al. Alpha-tocopherol and beta-carotene supplements and lung cancer incidence in the alpha-tocopherol, beta-carotene cancer prevention study: effects of base-line characteristics and study compliance. J Natl Cancer Inst. 1996; 88:1560-70.

Dietary supplementation with n-3 polyunsaturated fatty acids and vitamin E after myocardial infarction: results of the GISSI-Prevenzione trial. Gruppo Italiano per lo Studio della Sopravvivenza nell’Infarto miocardico. Lancet. 1999; 354:447–55.

Milman U, Blum S, Shapira C, et al. Vitamin E supplementation reduces cardiovascular events in a subgroup of middle-aged individuals with both type 2 diabetes mellitus and the haptoglobin 2-2 genotype. A prospective double-blinded clinical trial. Arterioscler Thromb Vasc Biol. 2007:ATVBAHA.107.153965.

Hennekens CH, Buring JE, Manson JE, et al. Lack of effect of long-term supplementation with beta-carotene on the incidence of malignant neoplasms and cardiovascular disease. N Engl J Med. 1996; 334:1145–49.

Hercberg S, Galan P, Preziosi P, et al. The SU.VI.MAX Study: a randomized, placebo-controlled trial of the health effects of antioxidant vitamins and minerals. Arch Intern Med. 2004; 164:2335–42.

A randomized, placebo-controlled, clinical trial of high-dose supplementation with vitamins C and E, beta-carotene, and zinc for age-related macular degeneration and vision loss: AREDS report no. 8. Arch Ophthalmol. 2001; 119:1417-36.

Omenn GS, Goodman GE, Thornquist MD, et al. Effects of a combination of beta-carotene and vitamin A on lung cancer and cardiovascular disease. N Engl J Med. 1996; 334:1150-55.

Hercberg S, Ezzedine K, Guinot C, et al. Antioxidant supplementation increases the risk of skin cancers in women but not in men. J Nutr. 2007; 137:2098-105.

Semba RD, Ferrucci L, Bartali B, Urpi-Sarda M, Zamora-Ross R, Sun K, Cherubini A, Bandinelli S, Andres-Lacueva C.  Resveratol levels and all-cause mortality in older community-dwelling adults. JAMA Intern Med. 174(7):1077-84

Dysken MW, Sano M, Asthana S, et al. Effect of Vitamin E and Memantine on Functional Decline in Alzheimer Disease: The TEAM-AD VA Cooperative Randomized Trial. JAMA. 2014;311(1):33-44.

Marchese ME, Kumar R,Colangelo LA, Avila PC, Jacobs DR Jr, Gross M, Sood A, Lui K, Cook-Mills JM. The vitamin E isoforms α-tocopherol and γ-tocopherol have opposite associations with spirometric parameters: the CARDIA study. Respiratory Research 182(7):4395-405.

Berdnikovs S, Abdala-Valencia H, McCary C, Somand M, Cole R, Garcia A, Bryce P, Cook Mills JM. Isoforms of vitamin E have opposing immunoregulatory functions during inflammation by reducing leukocyte recruitment. J Immunol. 182(7):4395-405

Grodstein F, Kang JH, Glynn RJ, Cook NR, Gaziano JM. A randomized trial of beta-carotene supplementation and cognitive function in men: the Physicians’ Health Study II. Arch Intern Med. 2007; 167:2184–90.

Lee IM, Cook NR, Gaziano JM, et al. Vitamin E in the primary prevention of cardiovascular disease and cancer: the Women’s Health Study: a randomized controlled trial. JAMA. 2005; 294:56–65.

Cook NR, Albert CM, Gaziano JM, et al. A randomized factorial trial of vitamins C and E and beta-carotene in the secondary prevention of cardiovascular events in women: results from the Women’s Antioxidant Cardiovascular Study. Arch Intern Med. 2007; 167:1610–18.

Duffield-Lillico AJ, Reid ME, Turnbull BW, et al. Baseline characteristics and the effect of selenium supplementation on cancer incidence in a randomized clinical trial: A summary report of the nutritional prevention of cancer trial. Cancer Epidemiol Biomarkers Prev. 2002; 11:630–39.

Vina J, Gomez-Cabrera MC, Lloret A, Marquez R, Minana JB, Pallardo FV, and Sastre J. Free radicals in exhaustive physical exercise: mechanism of production and protection by antioxidants. IUBMB Life 50: 271–217, 2000.

Wang YX, Zhang CL, Yu RT, Cho HK, Nelson MC, Bayuga-Ocampo CR, Ham J, Kang H, and Evans RM. Regulation of muscle fiber type and running endurance by PPARδ. Plos Biol 2: e294: 1532–1539, 2004.

Willett WC, Dietz WH, and Colditz GA. Guidelines for healthy weight. N Engl J Med 341: 427–434, 1999.

Yang CS and Wang ZY. Tea and cancer. J Natl Cancer Inst 85: 1038–1049, 1993.

Zhang Y and Wells JN. The effects of chronic caffeine administration on peripheral adenosine receptors. J Pharmacol Exp Ther 254: 757–763, 1990

McKenna DJ, Hughes K, Jones K. Green tea monograph. Alt Ther. 2000;6(3):61-84.

Miura Y, Chiba T, Tomita I, et al. Tea catechins prevent the development of atherosclerosis in apoprotein E-deficient mice. J Nutr. 2001;131(1):27-32.

Pi-Sunyer FX. Health implications of obesity. Am J Clin Nutr 1991;53:1595–603.

Seidell JC, Verschuren WM, van Leer EM, Kromhout D. Overweight, underweight, and mortality: a prospective study of 48,287 men and women. Arch Intern Med 1996;156:958–63.

Kannel WB, Cupples LA, Ramaswami R, Stokes J, Kreger BE, Higgins M. Regional obesity and risk of cardiovascular disease: the Framingham Study. J Clin Epidemiol 1991;44:183–90.

Fricker J, Fumeron F, Clair D, Apfelbaum M. A positive correlation between energy intake and BMI in a population of 1312 overweight subjects. Int J Obes 1989;13:663–81.

Nelson LH, Tucker LA. Diet composition related to body fat in a multivariate study of 203 men. J Am Diet Assoc 1996;96:771–7.

Peterson J, Dwyer J, Jacques P, et al. Tea variety and brewing techniques influence flavonoid content of black tea. Journal of Food Composition and Analysis 2004; 17(3–4):397–405. [Journal AbstractExit Disclaimer]

Arts ICW, van de Putte B, Hollman PCH. Catechin contents of foods commonly consumed in the Netherlands. 2. Tea, wine, fruit juices, and chocolate milk. Journal of Agricultural and Food Chemistry 2000; 48(5):1752–1757.

Henning SM, Fajardo-Lira C, Lee HW, et al. Catechin content of 18 teas and a green tea extract supplement correlates with the antioxidant capacity. Nutrition and Cancer 2003; 45(2):226–235.
Henning SM, Niu Y, Lee NH, et al. Bioavailability and antioxidant activity of tea flavanols after consumption of green tea, black tea, or a green tea extract supplement. American Journal of Clinical Nutrition 2004; 80(6):1558–1564.
Lambert JD, Yang CS. Mechanisms of cancer prevention by tea constituents. Journal of Nutrition 2003; 133(10):3262S–3267S

Zaveri NT. Green tea and its polyphenolic catechins: Medicinal uses in cancer and noncancer applications. Life Sciences 2006; 78(18):2073–2080.

Elmets CA, Singh D, Tubesing K, et al. Cutaneous photoprotection from ultraviolet injury by green tea polyphenols. Journal of the American Academy of Dermatology 2001; 44(3):425–432.

Seeram NP, Henning SM, Niu Y, et al. Catechin and caffeine content of green tea dietary supplements and correlation with antioxidant capacity. Journal of Agricultural and Food Chemistry 2006; 54(5):1599–1603.

Mukhtar H, Ahmad N. Tea polyphenols: Prevention of cancer and optimizing health. American Journal of Clinical Nutrition 2000; 71(6 Suppl):1698S–1702S.

Cabrera C, Giménez R, López MC. Determination of tea components with antioxidant activity. Journal of Agricultural and Food Chemistry 2003; 51(15):4427–4435.

Cabrera C, Artacho R, Giménez R. Beneficial effects of green tea―a review. Journal of the American College of Nutrition 2006; 25(2):79–99.

Reto M, Figueira ME, Filipe HM, Almeida CM. Chemical composition of green tea (Camellia sinensis) infusions commercialized in Portugal. Plant Foods for Human Nutrition 2007; 62(4):139–144.

Wu AH, Yu MC. Tea, hormone-related cancers and endogenous hormone levels. Molecular Nutrition and Food Research 2006; 50(2):160–169.

Steele VE, Kelloff GJ, Balentine D, et al. Comparative chemopreventive mechanisms of green tea, black tea and selected polyphenol extracts measured by in vitro bioassays. Carcinogenesis 2000; 21(1):63–67.

Chow HH, Hakim IA, Vining DR, et al. Effects of dosing condition on the oral bioavailability of green tea catechins after single-dose administration of polyphenon E in healthy individuals. Clinical Cancer Research 2005; 11(12):4627–4633.

Chow HS, Cai Y, Hakim IA, et al. Pharmacokinetics and safety of green tea polyphenols after multiple-dose administration of epigallocatechin gallate and polyphenon E in healthy individuals. Clinical Cancer Research 2003; 9(9):3312–3319.

Matsuyama T, Tanaka Y, Kamimaki I, Nagao T, Tokimitsu I. Catechin safely improved higher levels of fatness, blood pressure, and cholesterol in children. Obesity 2008; 16(6):1338–1348.

Higdon JV, Frei B. Coffee and health: A review of recent human research. Critical Reviews in Food Science and Nutrition 2006; 46(2):101–123.

Nawrot P, Jordan S, Eastwood J, et al. Effects of caffeine on human health. Food Additives and Contaminants 2003; 20(1):1–30.

Chin JM, Merves ML, Goldberger BA, Sampson-Cone A, Cone EJ. Caffeine content of brewed teas. Journal of Analytical Toxicology 2008; 32(8):702–704.

Nelson M, Poulter J. Impact of tea drinking on iron status in the UK: A review. Journal of Human Nutrition and Dietetics 2004; 17(1):43–54.

August DA, Landau J, Caputo D, et al. Ingestion of green tea rapidly decreases prostaglandin E2 levels in rectal mucosa in humans. Cancer Epidemiology, Biomarkers and Prevention 1999; 8(8):709–713.

Sun CL, Yuan JM, Koh WP, Lee HP, Yu MC. Green tea and black tea consumption in relation to colorectal cancer risk: The Singapore Chinese Health Study. Carcinogenesis 2007; 28(10):2143–2148.

Yang G, Shu XO, Li H, et al. Prospective cohort study of green tea consumption and colorectal cancer risk in women. Cancer Epidemiology, Biomarkers and Prevention 2007; 16(6):1219–1223.

Yuan JM, Gao YT, Yang CS, Yu MC. Urinary biomarkers of tea polyphenols and risk of colorectal cancer in the Shanghai Cohort Study. International Journal of Cancer 2006; 120(6):1344–1350.

Simons CC, Leurs Lj, Weijenberg MP, et al. Fluid intake and colorectal cancer risk in the Netherlands Cohort Study. Nutrition and Cancer 2010; 62(3):307–321.

Zhang X, Albanes D, Beeson LW, et al. Risk of colon cancer and coffee, tea, and sugar-sweetened soft drink intake: Pooled analysis of prospective cohort studies. Journal of the National Cancer Institute 2010; 102(11):771–783.

Ganmaa D, Willett WC, Li TY, et al. Coffee, tea, caffeine and risk of breast cancer: A 22-year follow-up. International Journal of Cancer 2008; 122(9):2071–2076.

Inoue M, Robien K, Wang R, et al. Green tea intake, MTHFR/TYMS genotype and breast cancer risk: The Singapore Chinese Health Study. Carcinogenesis 2008; 29(10):1967–1972.

Zhang M, Holman CD, Huang J-P, Xie X. Green tea and the prevention of breast cancer: A case-control study in Southeast China. Carcinogenesis 2007; 28(5):1074–1078.

Zhang M, Huang J, Xie X, Holman CD. Dietary intakes of mushrooms and green tea combine to reduce the risk of breast cancer in Chinese women. International Journal of Cancer 2009; 124(6):1404–1408.

Shrubsole MJ, Lu W, Chen Z, et al. Drinking green tea modestly reduces breast cancer risk. Journal of Nutrition 2009; 139(2):310–316.

Kumar N, Titus-Ernstoff L, Newcomb P, et al. Tea consumption and risk of breast cancer. Cancer Epidemiology, Biomarkers and Prevention 2009; 18(1):341–345.

Ogunleye AA, Xue F, Michels KB. Green tea consumption and breast cancer risk or recurrence: A meta-analysis. Breast Cancer Research and Treatment 2010; 119(2):477–484.

Larsson SC, Bergkvist L, Wolk A. Coffee and black tea consumption and risk of breast cancer by estrogen and progesterone receptor status in a Swedish cohort. Cancer Causes and Control 2009; 20(10):2039–2044.

Luo J, Gao Y-T, Chow WH, et al. Urinary polyphenols and breast cancer risk: Results from the Shanghai Women’s Health Study. Breast Cancer Research and Treatment 2010; 120(3):693–702.

Bhoo Pathy N, Peeters P, van Gils C, et al. Coffee and tea intake and risk of breast cancer. Breast Cancer Research and Treatment 2010; 121(2):461–467.

Dai Q, Shu XO, Li H, et al. Is green tea drinking associated with a later onset of breast cancer? Annals of Epidemiology 2010; 20(1):74–81

Gates MA, Tworoger SS, Hecht JL, et al. A prospective study of dietary flavonoid intake and incidence of epithelial ovarian cancer. International Journal of Cancer 2007; 121(10):2225–2232.

Silvera SA, Jain M, Howe GR, Miller AB, Rohan TE. Intake of coffee and tea and risk of ovarian cancer: A prospective cohort study. Nutrition and Cancer 2007; 58(1):22–27.

Steevens J, Schouten LJ, Verhage BA, Goldbohm RA, van den Brandt PA. Tea and coffee drinking and ovarian cancer risk: Results from the Netherlands Cohort Study and a meta-analysis. British Journal of Cancer 2007; 97(9):1291–1294.

Mandel SA, Avramovich-Tirosh Y, Reznichenko L, Zheng H, Weinreb O, Amit T, Youdim MB. Green tea catechins in neuroprotection. Neurosignals. 2005;14(1-2):46-60. PubMed

Wahyudi S, Sargowo D. Green tea polyphenols inhibit oxidized LDL-induced NF-KB activation in human umbilical vein endothelial cells. Acta Med Indones. 2007 Apr-Jun;39(2):66-70. PubMed

Osada K, Takahashi M, Hoshina S, Nakamura M, Nakamura S, Sugano M. Tea catechins inhibit cholesterol oxidation accompanying oxidation of low density lipoprotein in vitro. Comp Biochem Physiol C Toxicol Pharmacol. 2001 Feb;128(2):153-64. PubMed

Kang WS, Lim IH, Yuk DY, Chung KH, Park JB, Yoo HS, Yun YP. Antithrombotic activities of green tea catechins and (-)-epigallocatechin gallate. Thromb Res. 1999 Nov 1;96(3):229-37. PubMed

Murase T, Haramizu S, Shimotoyodome A, Nagasawa A, Tokimitsu I. Am J Physiol Regul Integr Comp Physiol. 2005 Mar;288(3):R708-15.

Hakim IA, Harris RB, Brown S, Chow HH, Wiseman S, Agarwal S, Talbot W. Increased tea consumption and oxidative DNA damage among smokers. J Nutr. 2003 Oct;133(10):3303S-3309S.

Kim W, Jeong MH, Cho SH, Yun JH, Chae HJ, Ahn YK, Lee MC, Cheng X, Kondo T, Murohara T, Kang JC. Circ J. 2006 Aug;70(8):1052-7. PubMed

Baker JA, Boakye K, McCann SE, et al. Consumption of black tea or coffee and risk of ovarian cancer. International Journal of Gynecological Cancer 2007; 17(1):50–54.

Song YJ, Kristal AR, Wicklund KG, Cushing-Haugen KL, Rossing MA. Coffee, tea, colas, and risk of epithelial ovarian cancer. Cancer Epidemiology, Biomarkers and Prevention 2008; 17(3):712–716.

Zhou B, Yang L, Wang L, et al. The association of tea consumption with ovarian cancer risk: A metaanalysis. American Journal of Obstetrics and Gynecology 2007; 197(6):594.e1–e6.

Wang L, Lee IM, Zhang SM, et al. Dietary intake of selected flavonols, flavones, and flavonoid-rich foods and risk of cancer in middle-aged and older women. American Journal of Clinical Nutrition 2009; 89(3):905–912.

Nagle CM, Olsen CM, Bain CJ, et al. Tea consumption and risk of ovarian cancer. Cancer Causes and Control 2010; 21(9):1485–1491.

Kurahashi N, Sasazuki S, Iwasaki M, Inoue M, Tsugane S. Green tea consumption and prostate cancer risk in Japanese men: A prospective study. American Journal of Epidemiology 2008; 167(1):71–77.

Erba D , Riso P , Bordoni A , Foti P , Biagi PL , Testolin G . Effectiveness of moderate green tea consumption on antioxidative status and plasma lipid profile in humans . J Nutr Biochem . 2005;16(3):144-149.

Hakim IA , Harris RB , Brown S , et al. Effect of increased tea consumption on oxidative DNA damage among smokers: a randomized controlled study . J Nutr . 2003;133(10):3303S-3309S.

Jian L, Lee AH, Binns CW. Tea and lycopene protect against prostate cancer. Asian Pacific Journal of Clinical Nutrition 2007; 16(Suppl 1):453–457.

Li Q, Kakizaki M, Kuriyama S, et al. Green tea consumption and lung cancer risk: The Ohsaki study. British Journal of Cancer 2008; 99(7):1179–1184.

Cui Y, Morgenstern H, Greenland S, et al. Dietary flavonoid intake and lung cancer—a population-based case-control study. Cancer 2008; 112(10):2241–2248.

Kubík A, Zatloukal P, Tomášek L, et al. A case-control study of lifestyle and lung cancer associations by histological types. Neoplasma 2008; 55(3):192–199.

Kubík A, Zatloukal P, Tomášek L, et al. Interactions between smoking and other exposures associated with lung cancer risk in women: Diet and physical activity. Neoplasma 2007; 54(1):83–88.

Tang N, Wu Y, Zhou B, Wang B, Yu R. Green tea, black tea consumption and risk of lung cancer: A meta-analysis. Lung Cancer 2009; 65(3):274–283

Li N, Sun Z, Han C, Chen J. The chemopreventive effects of tea on human oral precancerous mucosa lesions. Proceedings from the Society of Experimental Biology and Medicine 1999; 220(4):218–224. [PubMed Abstract]

Tsao AS, Liu D, Martin J, et al. Phase II randomized, placebo-controlled trial of green tea extract in patients with high-risk oral premalignant lesions. Cancer Prevention Research 2009; 2(11):931–941.

Hakim IA, Harris RB, Brown S, et al. Effect of increased tea consumption on oxidative DNA damage among smokers: A randomized controlled study. Journal of Nutrition 2003; 133(10):3303S–3309S.

Luo H, Tang L, Tang M, et al. Phase IIa chemoprevention trial of green tea polyphenols in high-risk individuals of liver cancer: Modulation of urinary excretion of green tea polyphenols and 8-hydroxydeoxyguanosine. Carcinogenesis 2006; 27(2):262–268.

Bettuzzi S, Brausi M, Rizzi F, et al. Chemoprevention of human prostate cancer by oral administration of green tea catechins in volunteers with high-grade prostate intraepithelial neoplasia: A preliminary report from a one-year proof-of-principle study. Cancer Research 2006; 66(2):1234–1240.

Jatoi A, Ellison N, Burch PA, et al. A phase II trial of green tea in the treatment of patients with androgen independent metastatic prostate carcinoma. Cancer 2003; 97(6):1442–1446.

Choan E, Segal R, Jonker D, et al. A prospective clinical trial of green tea for hormone refractory prostate cancer: An evaluation of the complementary/alternative therapy approach. Urologic Oncology: Seminars and Original Investigations 2005; 23(2):108–113.

Hamajima N, Tajima K, Tominaga S, et al. Tea polyphenol intake and changes in serum pepsinogen levels. Japanese Journal of Cancer Research 1999; 90(2):136–143.

Wang LD, Zhou Q, Feng CW, et al. Intervention and follow-up on human esophageal precancerous lesions in Henan, northern China, a high-incidence area for esophageal cancer. Gan To Kagaku Ryoho 2002; 29(Suppl 1):159–172.

Camellia sinensis . USDA, NRCS. 2010. The PLANTS Database ( http://plants.usda.gov 8 April 2010). National Plant Data Center, Baton Rouge, LA 70874-4490 USA.

Cooper R , Morré DJ , Morré DM . Medicinal benefits of green tea: part I. Review of noncancer health benefits . J Altern Complement Med . 2005;11(3):521-528.

McKay DL , Blumberg JB . The role of tea in human health: an update . J Am Coll Nutr . 2002;21(1):1-13.

Siddiqui IA , Afaq F , Adhami VM , Ahmad N , Mukhtar H . Antioxidants of the beverage tea in promotion of human health . Antioxid Redox Signal . 2004;6(3):571-582.

Blumberg J . Introduction to the proceedings of the Third International Scientific Symposium on Tea and Human Health: Role of Flavonoids in the Diet . J Nutr . 2003;133(10):3244S-3246S.

Dalluge JJ , Nelson BC , Thomas JB , Welch MJ , Sander LC . Capillary liquid chromatography/electrospray mass spectrometry for the separation and detection of catechins in green tea and human plasma . Rapid Commun Mass Spectrom . 1997;11(16):1753-1756.

Boehm K, Borrelli F, Ernst E, et al. Green tea ( Camellia sinensis ) for the prevention of cancer. Cochrane Database Syst Rev . 2009;(3):CD005004.

Luczaj W , Skrzydlewska E . Antioxidative properties of black tea . Prev Med . 2005;40(6):910-918.

Cooper R, Morré DJ, Morré DM. Medicinal benefits of green tea: part II. Review of anticancer properties. J Altern Complement Med . 2005;11(4):639-652.

Hodgson JM, Puddey IB, Croft KD, et al. Acute effects of ingestion of black and green tea on lipoprotein oxidation. Am J Clin Nutr . 2000;71(5):1103-1107

Young JF , Dragstedt LO , Haraldsdóttir J , et al. Green tea extract only affects markers of oxidative status postprandially: lasting antioxidant effect of flavonoid-free diet . Br J Nutr . 2002;87(4):343-355.

Leenen R , Roodenburg AJ , Tijburg LB , Wiseman SA . A single dose of tea with or without milk increases plasma antioxidant activity in humans . Eur J Clin Nutr . 2000;54(1):87-92.

Rietveld A , Wiseman S . Antioxidant effects of tea: evidence from human clinical trials . J Nutr . 2003;133(10):3285S-3292S.

Meltzer SM, Monk BJ, Tewari KS. Green tea catechins for treatment of external genital warts. Am J Obstet Gynecol . 2009;200(3):233.e1-233.e7.

Fujiki H , Suganuma M , Okabe S , et al. Cancer prevention with green tea and monitoring by a new biomarker, hnRNP B1 . Mutat Res . 2001;480-481:299-304.

Percival SS, Bukowski JF, Milner J. Bioactive food components that enhance gamma delta T cell function may play a role in cancer prevention. J Nutr . 2008;138(1):1-4.

Chung FL , Schwartz J , Herzog CR , Yang YM . Tea and cancer prevention: studies in animals and humans . J Nutr . 2003;133(10):3268S-3274S.

Hou Z , Lambert JD , Chin KV , Yang CS . Effects of tea polyphenols on signal transduction pathways related to cancer chemoprevention . Mutat Res . 2004;555(1-2):3-19.

Nagata C , Kabuto M , Shimizu H . Association of coffee, green tea, and caffeine intakes with serum concentrations of estradiol and sex hormone-binding globulin in premenopausal Japanese women . Nutr Cancer . 1998;30(1):21-24.

Vita JA . Tea consumption and cardiovascular disease: effects on endothelial function . J Nutr . 2003;133(10):3293S-3297S.

Thielecke F, Boschmann M. The potential role of green tea catechins in the prevention of the metabolic syndrome – a review. Phytochemistry . 2009;70(1):11-24.

Babu A, Liu D. Green tea catechins and cardiovascular health: an update. Curr Med Chem . 2008;15(18):1840-1850.

Hooper L, Kroon PA, Rimm EB, et al. Flavonoids, flavonoid-rich foods, and cardiovascular risk: a meta-analysis of randomized controlled trials. Am J Clin Nutr . 2008;88(1):38-50.

Matsuyama T, Tanaka Y, Kamimaki I, Nagao T, Tokimitsu I. Catechin safely improved higher levels of fatness, blood pressure, and cholesterol in children. Obesity (Silver Spring) . 2008;16(6):1338-1348.

Nantz MP, Rowe CA, Bukowski JF, Percival SS. Standardized capsule of Camellia sinensis lowers cardiovascular risk factors in a randomized, double-blind, placebo-controlled study. Nutrition . 2009;25(2):147-154.

Frank J, George TW, Lodge JK, et al. Daily consumption of an aqueous green tea extract supplement does not impair liver function or alter cardiovascular disease risk biomarkers in healthy men. J Nutr . 2009;139(1):58-62.

Hsu CH, Tsai TH, Kao YH, Hwang KC, Tseng TY, Chou P. Effect of green tea extract on obese women: a randomized, double-blind, placebo-controlled clinical trial. Clin Nutr . 2008;27(3):363-370.

Maki KC, Reeves MS, Farmer M, et al. Green tea catechin consumption enhances exercise-induced abdominal fat loss in overweight and obese adults. J Nutr . 2009;139(2):264-270.

Brown AL, Lane J, Coverly J, et al. Effects of dietary supplementation with the green tea polyphenol epigallocatechin-3-gallate on insulin resistance and associated metabolic risk factors: randomized controlled trial. Br J Nutr . 2009;101(6):886-894.

Fukino Y, Ikeda A, Maruyama K, Aoki N, Okubo T, Iso H. Randomized controlled trial for an effect of green tea-extract powder supplementation on glucose abnormalities. Eur J Clin Nutr . 2008;62(8):953-960.

Sun AY, Wang Q, Simonyi A, Sun GY. Botanical phenolics and brain health. Neuromolecular Med . 2008;10(4):259-274.

Mandel SA, Amit T, Kalfon L, Reznichenko L, Weinreb O, Youdim MB. Cell signaling pathways and iron chelation in the neurorestorative activity of green tea polyphenols: special reference to epigallocatechin gallate (EGCG). J Alzheimers Dis . 2008;15(2):211-222.

Cho HS, Kim S, Lee SY, Park JA, Kim SJ, Chun HS. Protective effect of the green tea component, L-theanine on environmental toxins-induced neuronal cell death. Neurotoxicology . 2008;29(4):656-662.

Mandel S , Weinreb O , Amit T , Youdim MB . Cell signaling pathways in the neuroprotective actions of the green tea polyphenol (-)-epigallocatechin-3-gallate: implications for neurodegenerative diseases [published correction appears in J Neurochem . 2004;89(2):527]. J Neurochem . 2004;88(6):1555-1569.

Weinreb O , Mandel S , Amit T , Youdim MB . Neurological mechanisms of green tea polyphenols in Alzheimer’s and Parkinson’s diseases . J Nutr Biochem . 2004;15(9):506-516.

L-theanine. Monograph. Altern Med Rev . 2005;10(2):136-138.

Nagao T, Meguro S, Hase T, et al. A catechin-rich beverage improves obesity and blood glucose control in patients with type 2 diabetes. Obesity (Silver Spring) . 2009;17(2):310-317.

Mackenzie T, Leary L, Brooks WB. The effect of an extract of green and black tea on glucose control in adults with type 2 diabetes mellitus: double-blind randomized study. Metabolism . 2007;56(10):1340-1344.

Hosoda K , Wang MF , Liao ML , et al. Antihyperglycemic effect of oolong tea in type 2 diabetes . Diabetes Care . 2003;26(6):1714-1718.

Venables MC, Hulston CJ, Cox HR, Jeukendrup AE. Green tea extract ingestion, fat oxidation, and glucose tolerance in healthy humans. Am J Clin Nutr . 2008;87(3):778-784.

Dulloo AG , Duret C , Rohrer D , et al. Efficacy of a green tea extract rich in catechin polyphenols and caffeine in increasing 24-h energy expenditure and fat oxidation in humans . Am J Clin Nutr . 1999;70(6):1040-1045.

Kovacs EM , Lejeune MP , Nijs I , Westerterp-Plantenga MS . Effects of green tea on weight maintenance after body-weight loss . Br J Nutr . 2004;91(3):431-437.

Hursel R, Westerterp-Plantenga MS. Green tea catechin plus caffeine supplementation to a high-protein diet has no additional effect on body weight maintenance after weight loss. Am J Clin Nutr . 2009;89(3):822-830.

Fraser ML, Mok GS, Lee AH. Green tea and stroke prevention: emerging evidence. Complement Ther Med . 2007;15(1):46-53.

Muraki S, Yamamoto S, Ishibashi H, Oka H, Yoshimura N, Kawaguchi H, Nakamura K. Diet and lifestyle associated with increased bone mineral density. J Orthop Sci. 2007 Jul;12(4):317-20.

Devine A, Hodgson JM, Dick IM, Prince RL. Tea drinking is associated with benefits on bone density in older women. Am J Clin Nutr. 2007 Oct;86(4):1243-7.

You SQ. Feasibility of Chinese green tea polyphenols (CTP) for preventing dental caries. Zhonghua Kou Qiang Yi Xue Za Zhi. 1993 Jul;28(4):197-9, 254. PubMed

Adcocks C, Collin P, Buttle DJ. Catechins from green tea (Camellia sinensis) inhibit bovine and human cartilage proteoglycan and type II collagen degradation in vitro. J Nutr. 2002 Mar;132(3):341-6.

Gradisar H, Pristovsek P, Plaper A, Jerala R. J Med Chem. 2007 Jan 25;50(2):264-71. PubMed

Chen X, Li W, Wang H. Green tea may reduce endotoxin-induced release of high mobility group box 1 and other pro-inflammatory cytokines. Med Hypotheses. 2006;66(3):660-3.

Imai K, Nakachi K. Drinking green tea and liver. BMJ. 1995 Mar 18;310(6981):693-6.

Shibata K, Moriyama M, Fukushima T, Kaetsu A, Miyazaki M, Une H. Green tea consumption and chronic atrophic gastritis. J Epidemiol. 2000 Sep;10(5):310-6. PubMed

Arab L, Liu W, Elashoff D. Green and black tea consumption and risk of stroke: a meta-analysis. Stroke . 2009;40(5):1786-1792.

Li YH, Wu Y, Wei HC, et al. Protective effects of green tea extracts on photoaging and photommunosuppression. Skin Res Technol . 2009;15(3):338-345.

Toda M , Okubo S , Ohnishi R , Shimamura T . Antibacterial and bactericidal activities of Japanese green tea [in Japanese]. Nippon Saikingaku Zasshi . 1989;44(4):669-672.

Yam TS , Shah S , Hamilton-Miller JM . Microbiological activity of whole and fractionated crude extracts of tea ( Camellia sinensis ) and of tea components . FEMS Microbiol Lett . 1997;152(1):169-174.

Isogai E , Isogai H , Takeshi K , Nishikawa T . Protective effect of Japanese green tea extract on gnotobiotic mice infected with an Escherichia coli O157:H7 strain . Microbiol Immunol . 1998;42(2):125-128.

Bezbaruah B , Kumar BS , Barthakur M . Fungicidal and insect controlling properties of Proteus strain RRLJ 16, isolated from tea, Camellia sinensis (L) O Kuntze, plantations . Indian J Exp Biol . 1996;34(7):706-709.

Hamilton-Miller JM . Anti-cariogenic properties of tea ( Camellia sinensis ) . J Med Microbiol . 2001;50(4):299-302.

Koo MW , Cho CH . Pharmacological effects of green tea on the gastrointestinal system . Eur J Pharmacol . 2004;500(1-3):177-185.

Chow HH , Cai Y , Hakim IA , et al. Pharmacokinetics and safety of green tea polyphenols after multiple-dose administration of epigallocatechin gallate and polyphenon E in healthy individuals . Clin Cancer Res . 2003;9(9):3312-3319.

Spencer JP . Metabolism of tea flavonoids in the gastrointestinal tract . J Nutr . 2003;133(10):3255S-3261S.

Henning SM , Niu Y , Lee NH , et al. Bioavailability and antioxidant activity of tea flavanols after consumption of green tea, black tea, or a green tea extract supplement . Am J Clin Nutr . 2004;80(6):1558-1564.

He YH , Kies C . Green and black tea consumption by humans: impact on polyphenol concentrations in feces, blood and urine . Plant Foods Hum Nutr . 1994;46(3):221-229.

Mulder TP , Rietveld AG , von Amelsvoort JM . Consumption of both black tea and green tea results in an increase in the excretion of hippuric acid into urine . Am J Clin Nutr . 2005;81(1)(suppl):256S-260S.

Chow HH , Hakim IA , Vining DR , et al. Effects of dosing condition on the oral bioavailability of green tea catechins after single-dose administration of Polyphenon E in healthy individuals . Clin Cancer Res . 2005;11(12):4627-4633.

van het Hof KH , Kivits GA , Weststrate JA , Tijburg LB . Bioavailability of catechins from tea: the effect of milk . Eur J Clin Nutr . 1998;52(5):356-359.

Sarma DN, Barrett ML, Chavez ML, et al. Safety of green tea extracts: a systematic review by the US Pharmacopeia. Drug Saf . 2008;31(6):469-484.

Briggs GG , Freeman RK , Yaffe SJ . Drugs in Pregnancy and Lactation: A Reference Guide to Fetal and Neonatal Risk . 3rd ed. Baltimore, MD: Williams & Wilkins; 1990.

Taylor JR , Wilt VM . Probable antagonism of warfarin by green tea . Ann Pharmacother . 1999;33(4):426-428.

Alemdaroglu NC, Dietz U, Wolffram S, Spahn-Langguth H, Langguth P. Influence of green and black tea on folic acid pharmacokinetics in healthy volunteers: potential risk of diminished folic acid bioavailability. Biopharm Drug Dispos . 2008;29(6):335-348.

Nelson M , Poulter J . Impact of tea drinking on iron status in the UK: a review . J Hum Nutr Diet . 2004;17(1):43-54.